Jim Simons
VNRX icon

Jim Simons’s VolitionRx Ltd VNRX Stock Holding History

Jim Simons’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,265
Closed -$6.47K – 3726
2025
Q4 		$6.47K Sell
1,265
-2,635
-68% -$20K ﹤0.01% 3176
2025
Q3 		$52.9K Buy
3,900
+2,875
+280% +$38.3K ﹤0.01% 3335
2025
Q2 		$15.6K Buy
+1,025
New +$11.3K ﹤0.01% 3486
2022
Q1 		– Sell
-565
Closed -$35K – 4503
2021
Q4 		$35K Sell
565
-5,870
-91% -$401K ﹤0.01% 3811
2021
Q3 		$399K Sell
6,435
-5,896
-48% -$373K ﹤0.01% 2977
2021
Q2 		$811K Buy
12,331
+10,831
+722% +$733K ﹤0.01% 2770
2021
Q1 		$113K Buy
+1,500
New +$129K ﹤0.01% 3214
2020
Q3 		– Sell
-1,439
Closed -$112K – 3719
2020
Q2 		$112K Buy
+1,439
New +$104K ﹤0.01% 3255
2020
Q1 		– Sell
-2,615
Closed -$248K – 3829
2019
Q4 		$248K Sell
2,615
-745
-22% -$77.2K ﹤0.01% 3129
2019
Q3 		$378K Buy
3,360
+2,515
+298% +$200K ﹤0.01% 2961
2019
Q2 		$53K Buy
845
+275
+48% +$17.8K ﹤0.01% 3448
2019
Q1 		$37K Buy
+570
New +$31.8K ﹤0.01% 3373

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return

Jim Simons's VNRX Position: Q1 2026 in Review

Jim Simons sold out of VolitionRx Ltd (VNRX) in Q1 2026, closing a stake of 1,265 shares — an estimated $6.47K sold.

Jim Simons first reported a position in VNRX in Q1 2019 and held it in 12 quarters. The position peaked at $811K in Q2 2021. 31 funds tracked by Wall St. Rank hold VNRX as of Q1 2026.

  • Jim Simons reported no remaining VolitionRx Ltd position as of Q1 2026 after selling out during the quarter.
  • Jim Simons sold 1,265 VolitionRx Ltd shares in Q1 2026, an estimated $6.47K.
  • Jim Simons first reported a position in VolitionRx Ltd in Q1 2019 and held it in 12 quarters.
  • Jim Simons's VolitionRx Ltd position peaked at $811K in Q2 2021.
  • 31 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.